Data / Research funding / Tennessee / ST. Jude Children's Research Hospital Graduate School of Biomedical Sciences, LLC
ST. Jude Children's Research Hospital Graduate School of Biomedical Sciences, LLC: 26 NIH awards ($2.1M), fiscal years 2021 to 2026
ST. Jude Children's Research Hospital Graduate School of Biomedical Sciences, LLC in Memphis, TN is funded under 26 NIH awards ($2.1M) in the NIH and NSF award files, read 2026-11-04. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
Get awards like theseWatch ST. Jude Children's Research Hospital Graduate School of Biomedical Sciences, LLC
- UEI
- MN2LFZNE4HH3
- State
- Tennessee
Awards
26 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Investigating essential chromatin regulators in cancers with SWI/SNF mutations | NIH | National Cancer Institute | 2023 to 2025 | $134,206 | May 1, 2023 | April 30, 2026 | MALONE, HAYDEN ABIGAIL | reporter.nih.gov |
| Cancer-associated fibroblasts and extracellular matrix remodeling in pediatric neuroblastoma | NIH | National Cancer Institute | 2022 to 2024 | $131,420 | September 1, 2022 | August 31, 2025 | PETERSON, NICOLAS | reporter.nih.gov |
| Oncofetal TNC CAR T Cell Therapy for Pediatric Sarcoma | NIH | National Cancer Institute | 2021 to 2023 | $128,482 | September 1, 2021 | August 31, 2024 | WICKMAN, ELIZABETH | reporter.nih.gov |
| Gpr182-mediated calcium mobilization is required for definitive hematopoiesis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $128,482 | September 1, 2021 | August 31, 2024 | WILLIAMSON, MCLEAN H | reporter.nih.gov |
| Regional selectivity of oncohistone H3K27M on glial development and glioma pathogenesis | NIH | National Cancer Institute | 2021 to 2023 | $128,482 | July 1, 2021 | June 30, 2024 | BUDD, KAITLIN | reporter.nih.gov |
| T Cell Responses to Neoantigens in Fibrolamellar Carcinoma | NIH | National Cancer Institute | 2021 to 2023 | $104,989 | April 1, 2021 | June 19, 2023 | KIRK, ALLISON MACKENZIE | reporter.nih.gov |
| Identifying the mechanisms behind non-apoptotic functions of mitochondrial matrix-localized MCL-1 | NIH | National Cancer Institute | 2022 to 2024 | $104,391 | August 1, 2022 | September 25, 2024 | WRIGHT, TRISTEN | reporter.nih.gov |
| Structural and evolutionary basis for insertion unidirectionality in RNA-guided DNA transposition systems | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $97,232 | September 1, 2024 | August 31, 2027 | TRUONG, VINH H | reporter.nih.gov |
| Determining the Role of SOX8 in Myogenesis and Rhabdomyosarcomagenesis | NIH | National Cancer Institute | 2024 to 2025 | $96,512 | February 1, 2024 | January 31, 2027 | STEVENS, BRADLEY | reporter.nih.gov |
| Investigating dysregulation of hematopoietic stem cell support in sickle cell disease mesenchymal stromal cells | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $88,668 | August 1, 2023 | July 31, 2025 | CAIN, TERRI | reporter.nih.gov |
| Mechanistic Studies of a Novel Vulnerability in Pediatric Cancer | NIH | National Cancer Institute | 2021 to 2022 | $87,288 | April 1, 2021 | March 31, 2023 | RADKO-JUETTNER, SANDI | reporter.nih.gov |
| Characterizing enhancers regulating transcription factor expression for cell-type specification across neurodevelopment | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $86,788 | September 1, 2021 | August 31, 2023 | HONNELL, VICTORIA | reporter.nih.gov |
| Development of Glypican-2 redirected T cells for the Treatment of Neuroblastoma | NIH | National Cancer Institute | 2021 to 2022 | $84,789 | January 1, 2021 | December 31, 2022 | BELL, MATTHEW | reporter.nih.gov |
| Determining the Mechanism of Transformation for Rhabdomyosarcoma | NIH | National Cancer Institute | 2021 to 2022 | $84,788 | January 1, 2021 | December 31, 2022 | SEARCY, MADELINE BUSH | reporter.nih.gov |
| Tofacitinib Analogs as Oxacillin Potentiators against MRSA | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $80,322 | February 1, 2023 | October 14, 2024 | PHELPS, GREGORY A | reporter.nih.gov |
| Molecular Mechanisms Underlying Cytoneme Formation by Sonic Hedgehog-Producing Cells | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2024 | $74,556 | May 1, 2023 | October 31, 2024 | DALY, CHRISTINA ADELE | reporter.nih.gov |
| Metabolic signaling dictates context-dependent Treg cell functional heterogeneity | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $68,468 | August 1, 2024 | September 9, 2025 | NORTON, ERIENNE GRACE | reporter.nih.gov |
| Understanding the Impact of Influenza A Virus Infection During Pregnancy | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $62,740 | January 1, 2022 | March 16, 2023 | VAZQUEZ-PAGAN, ANA | reporter.nih.gov |
| Strategies to Improve Influenza Vaccine Efficacy in High-Risk Obese Individuals | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $62,446 | September 1, 2022 | August 31, 2024 | WIGGINS, KRISTIN | reporter.nih.gov |
| A multi-omics approach to understanding pediatric epilepsies | NIH | National Human Genome Research Institute | 2025 | $49,474 | December 18, 2024 | November 30, 2026 | LAFLAMME, CHRISTY | reporter.nih.gov |
| Determining the Mechanism of Rhabdomyosarcoma Transformation from a Non-Myogenic Cell of Origin | NIH | National Cancer Institute | 2025 | $48,538 | May 13, 2025 | May 12, 2028 | ADKINS, GRACE ELIZABETH | reporter.nih.gov |
| Elucidating the Molecular Pathogenesis of PICALM::MLLT10 Pediatric Acute Myeloid Leukemia | NIH | National Cancer Institute | 2025 | $48,538 | July 21, 2025 | July 20, 2028 | EZZELL, LAUREN | reporter.nih.gov |
| Improvement of small molecule ClpP activators for use in hybrid antibiotics | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $48,538 | September 1, 2025 | August 31, 2028 | DUNN, CHRISTINE | reporter.nih.gov |
| Define and minimize the immunogenicity of CRISPR-Cas nucleases | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $37,236 | December 23, 2021 | LEE, ANDREA | reporter.nih.gov | |
| Investigating a novel role of DRAK2 in T cell migration and synapse formation | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $34,020 | August 1, 2023 | March 22, 2024 | WILANDER, BENJAMIN ANDREW | reporter.nih.gov |
| Role of the ETV6 transcription factor in hematopoietic stem cell function | NIH | National Heart, Lung, and Blood Institute | 2022 | $33,228 | January 1, 2021 | October 20, 2022 | BLOOM, MACKENZIE | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 8 | $359,196 | 0 | $0 |
| 2024 | 8 | $316,305 | 0 | $0 |
| 2023 | 14 | $546,843 | 0 | $0 |
| 2022 | 13 | $537,753 | 0 | $0 |
| 2021 | 9 | $374,524 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) | PA-24-254 | NIH | July 12, 2027 | Not listed | Notice number printed on 1 award here | |
| NCI Research Specialist Award for Core and Laboratory-based Scientists (R50 Clinical Trial Not Allowed) | PAR-27-088 | NIH | 93.398 | November 20, 2026 | Not listed | Same assistance listing 93.398 as 12 awards here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Required) | PAR-24-295 | NIH | 93.398 | December 3, 2026 | Not listed | Same assistance listing 93.398 as 12 awards here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) | PAR-24-296 | NIH | 93.398 | December 3, 2026 | Not listed | Same assistance listing 93.398 as 12 awards here |
| NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) | RFA-OD-24-011 | NIH | 93.398 | December 4, 2026 | Not listed | Same assistance listing 93.398 as 12 awards here |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) | RFA-LM-28-001 | NIH | 93.398 | February 11, 2027 | $775,000 | Same assistance listing 93.398 as 12 awards here |
| Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 Clinical Trials Not Allowed) | RFA-OD-25-003 | NIH | 93.398 | April 9, 2027 | $200,000 | Same assistance listing 93.398 as 12 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required) | PA-24-175 | NIH | 93.398 | May 7, 2027 | Not listed | Same assistance listing 93.398 as 12 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | PA-24-176 | NIH | 93.398 | May 7, 2027 | Not listed | Same assistance listing 93.398 as 12 awards here |
| Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Required) | PA-24-190 | NIH | 93.398 | May 7, 2027 | Not listed | Same assistance listing 93.398 as 12 awards here |
| Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed) | PA-24-191 | NIH | 93.398 | May 7, 2027 | Not listed | Same assistance listing 93.398 as 12 awards here |
| NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required) | PA-24-193 | NIH | 93.398 | May 7, 2027 | Not listed | Same assistance listing 93.398 as 12 awards here |
| NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed) | PA-24-194 | NIH | 93.398 | May 7, 2027 | Not listed | Same assistance listing 93.398 as 12 awards here |
| Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required) | PA-24-181 | NIH | 93.398 | May 8, 2027 | Not listed | Same assistance listing 93.398 as 12 awards here |
| Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed) | PA-24-182 | NIH | 93.398 | May 8, 2027 | Not listed | Same assistance listing 93.398 as 12 awards here |
| Successor-in-Interest (Type 6 Parent Clinical Trial Optional) | PA-24-253 | NIH | 93.398 | July 17, 2027 | Not listed | Same assistance listing 93.398 as 12 awards here |
| Investigator-Focused Award (Parent R35) | PAR-28-037 | NIH | 93.398 | October 4, 2027 | Not listed | Same assistance listing 93.398 as 12 awards here |
| NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed) | PAR-25-135 | NIH | 93.398 | October 14, 2027 | Not listed | Same assistance listing 93.398 as 12 awards here |
| NCI Pathway to Independence Award (K99/R00 Clinical Trial Required) | PAR-25-313 | NIH | 93.398 | October 14, 2027 | Not listed | Same assistance listing 93.398 as 12 awards here |
| Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32) | PA-25-168 | NIH | 93.398 | May 4, 2028 | Not listed | Same assistance listing 93.398 as 12 awards here |
Topics of its NIH awards
- Genetics
- Cancer
- Rare Diseases
- Pediatric
- Pediatric Cancer
- Biotechnology
- Stem Cell Research
- Neurosciences
- Immunotherapy
- Human Genome
- Orphan Drug
- Infectious Diseases
Updated November 4, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-04). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.